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ORIGINAL ARTICLE
Biochemical characterization of Acacia schweinfurthii serine
proteinase inhibitor
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1Department of Biochemistry & Microbiology, 2Department of Biomedical Sciences, Nelson Mandel Metropolitan University, Port Elizabeth,
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Abstract
One of the many control mechanisms of serine proteinases is their specific inhibition by protein
proteinase inhibitors. An extract of Acacia schweinfurthii was screened for potential serine
proteinase inhibition. It was successfully purified to homogeneity by precipitating with 80%
(v/v) acetone and sequential chromatographic steps, including ion-exchange, affinity purifica-
tion andQ2 RP-HPLC. Reducing SDS-PAGE conditions revealed an inhibitor (ASTI) consisting of two
polypeptide chains A and B of approximate molecular weights of 16 and 10 kDa, respectively,
and under non-reducing conditions, 26 kDa was observed. The inhibitor was shown to inhibit
bovine trypsin (Ki of 3.45 nM) at an approximate molar ratio of inhibitor: trypsin (1:1). The A- and
B-chains revealed complete sequences of 140 and 40 amino acid residues, respectively.
Sequence similarity (70%) was reported between ASTI A-chain and ACTI A-chain (Acacia
confusa) using the ClustalW. The B-chain produced a 76% sequence similarity between ASTI and
Leucaena leucocephala trypsin inhibitor.
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Introduction
Proteinases are the enzymes that catalyse the hydrolytic cleavage
of specific peptide bonds in their target proteins. These enzymes
are widely distributed in nearly all plants, animals and micro-
organisms and are very important for the maintenance and
survival of their host organism and play key roles in many
biological processes. The proteolytic events catalysed by these
enzymes serve as mediators of signal initiation, transmission and
termination in many of the cellular events, such as inflammation,
apoptosis, blood clotting and hormone processing pathways1.
Despite the fact that these enzymes are indispensable to the
cells and organisms that host them, they may be potentially
damaging when overexpressed or present in high concentrations.
For this reason, the activities of these enzymes need to be strictly
regulated and controlled. The synthesis of these enzymes as
inactive pre-proteins, and their substrate specificity exert a control
on their activities, but it does not fulfil the desired level of
regulation, and the fact remains, that cells and organisms require
additional means of control2.
One important control mechanism involves interaction of the
active enzymes with proteins that inhibit their activities. These
inhibitors form less active or fully inactive complexes with their
cognate enzymes. Interest in understanding the physiological
significance of proteinase inhibitors (PIs) has increased due
to their regulatory action in different processes related to the
proteinase-PI balance. The PIs are important tools to achieve a
better understanding of fundamental principles of protein inter-
action and can be used to design new substances for the control
of diseases and pathologic processes. PIs have drawn the attention
of many researchers due to their potential medical value, for
example, human immunodeficiency virus (HIV) PIs and severe
acute respiratory syndrome (SARS) coronavirus PIs may be used
to combat HIV and SARS virus, respectively3.
Most PIs interact with their target proteinases by contact
with the active (catalytic) site of the proteinase, resulting in the
formation of a stable PI complex that is incapable of enzymatic
activity4. With the exception of macroglobulin (720 kDa), which
inhibits proteinases of all classes, individual protein inhibitors
frequently inhibit proteinases belonging to a single mechanistic
class, although some inhibitors inhibit two different classes of
enzymes5–7. Of these inhibitors, the most studied classes are
the inhibitors of serine (Ser) proteinases. These inhibitors are also
very unique in that they retain their inhibitory activity after
replacement of their reactive site residue (P1) by another residue8.
PIs of plants are proteins that are natural, defence-related
proteins, often present in seeds and induced in certain tissues by
herbivory or wounding. Thus, their main function is thought to be
in plant defence, the regulation of endogenous proteinases,
as storage proteins, as well as the prevention of unwanted
proteolysis8,9. Plant PIs are shown to also possess anti-insect and
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anti-fungal activities, and have been reported to inhibit a variety
of Ser proteinases, including enzymes of the blood coagulation
cascade. They may also be involved in the regulation of
programmed cell death in plants10. Among the seed legumes,
the Ser proteinase Bowman–Birk inhibitor and Kunitz trypsin
inhibitor (KTI) have been studied extensively. These families
differ from each other in size, cysteine content and the number
of reactive sites. KTIs are proteins (18 000–24 000 Da), with one
or two polypeptide chains and low Cys content, usually with
four Cys residues connected by two disulphide bridges and a
single reactive site3.
Since the isolation of soybean trypsin inhibitor (SBTI) by
Kunitz11, it has been found that PIs are widely distributed
in seeds of the Leguminosae. Thus, Acacia schweinfurthii (AS)
var schweinfurthii belonging to the family, Leguminosae, and
sub family Mimosoideae, indigenous to South Africa, was
chosen for this study. Seeds from this plant served as a source
of potential inhibitor of Ser proteinases. We report in this
paper the purification and characterization of the inhibitor from
AS seeds.
Materials and methods
Materials
AS seeds were purchased from Kirstenbosch botanical garden
(Cape Town, South Africa). Trypsin, chymotrypsin and trypsin-
agarose resin were purchased from Sigma Aldrich (USAQ3 ), as well
as the substrates Z-Gly-Pro-Arg-pNA and N-Suc-Ala-Ala-
Pro-Phe-pNA. Toyopearl Super-Q 650 S and TSK ODS 120 T
column were from Tosoh (Japan). Molecular weight markers were
from Optima Scientific (South Africa). All other reagents were
of the highest analytical grade available.
Preparation of crude extract
Seeds were milled into a fine powder with a grinder. Twenty
grams of the milled seeds were extracted in 200 mL 0.15 M NaCl
as described by Joubert et al.12. The proteins were extracted by
homogenizing for approximately 10 s. The extract was stirred
slowly overnight at 4 C, followed by centrifugation at 5000 g
for 15 min at 4 C and the supernatant was kept for further
analysis. Proteins were re-extracted from the pellet as discussed
above and the supernatants were combined (crude extract).
Proteins in the supernatant were precipitated with 80% (v/v)
acetone at 4 C. Protein precipitates were recovered by centrifu-
gation at 5000 g for 10 min at 4 C. The pellets were
re-suspended in water and lyophilized for further studies.
Purification by chromatography
Protein from the acetone precipitated material (20 mg) was loaded
at 5 mL/h onto an ion exchange chromatography (IEC), Toyopearl
Super Q column (29 1.6 cm), equilibrated with 0.05M Tris-HCl
buffer, pH 7.5. After extensive washing at 40 mL/h, bound
material was eluted with a linear NaCl gradient (0–0.6 M) (total
volume, 200 mL), followed by 1 M NaCl to remove any bound
material left on the column. Fractions (3 mL) were collected
and the absorbances at 280 nm were monitored. The peaks that
contained inhibitory activity were pooled and a Sephadex G-10
column (64 1.6 cm) was used to desalt the fractions, equili-
brated with 0.5M ammonium acetate buffer, pH 8. The sample
was loaded at 10 mL/h and chromatography was performed at
40 mL/h. Fractions (3 mL) were collected and their absorbance
monitored at 280 nm. A trypsin-agarose resin (1.5 mL column)
was equilibrated with 10 mM acetic acid, pH 3.2. Protein was
applied at 0.5 mL/min and the column was washed with distilled
H2O, and eluted with 20 mM HCl, with the absorbance at 280 nm
being monitored. Fractions (1 mL) were collected. AS inhibitor
was further purified by RP-HPLC13 using a Grace Vydac C-18 RP
column. The column was equilibrated with 0.1% trifluoroacetic
acid (TFA)/water and eluted using an acetonitrile gradient
(0–20%, 5 min; 20–60%, 35 min; 60–100%, 15 min) in 0.1%
TFA at a flow rate of 1.0 mL/min. Fractions were collected and
freeze dried.
Protein quantification and SDS-PAGE analysis
The protein content of the various fractions was determined
by using the BCA protein determination assay according to the
method of Smith et al.14. The purity and molecular weight of
ASTI were determined using SDS-PAGE (15% resolving gel)
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Figure 1. (a) Toyopearl Super-Q chromatography of acetone extract
of AS (15 mg). The column (29 1.6 cm) was equilibrated with 0.05M
Tris-HCl buffer, pH 8.0 and a linear NaCl gradient (0–0.6 M) in 0.05 M
Tris-HCl buffer was used for elution. Flow rate was 0.6 mL/min. ASa:
tubes 5–12, ASb: tubes 110–135 and ASc: tubes 143–155. Approximately
over 95% inhibition of trypsin was observed for fraction ASb and less
than 10% was observed for ASa and ASc. (b) Affinity chromatography
of fraction ASb using a trypsin-agarose column (1 mL). The column
was equilibrated with 10 mM acetic acid and 20 mM HCl was used
for elution. Flow rate was 0.5 mL/min. ASb1: tubes 2–5, ASb2: tubes
8–11. (c) RP-HPLC of fraction ASb2 (500 mg) on a Grace Vydac C-18 RP
column. The column was equilibrated with 0.1% (v/v) TFA/water.
Elution was performed with an acetonitrile gradient at a flow rate of
1 mL/min.
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as described by Laemmli15, under reducing and non-reducing
conditions. Peq GOLD Protein-Marker II was used as MW
markers (10 000–200 000 Da) and bands were visualized by
staining with Coomassie brilliant blue R-250.
Amino acid sequence and phylogenetic analysis
Purified, intact ASTI was subjected to reduction, alkylation
and RP-HPLC16, allowing the two subunits to be separated.
S-carboxamidomethylated (CAM)-ASTI (A-chain) (0.5 mg)
was digested separately with endoproteinase Arg-C (5 mg,
S/E¼ 100:1) and Achromobacter protease I (10mg, S/E¼ 50:1)
in 0.5 mL 0.1 M Tris-HCl buffer (pH 7.6) containing 10 mM
CaCl2 at 37
C for 16 h. CAM-ASTI (A-chain) (0.5 mg) was
also digested with Staphylococcus aureus V8 protease (10 mg,
S/E¼ 50:1) in 0.5 mL 20 mM Tris-HCl buffer (pH 8.0) at 37 C
for 16 h17. Each digest was separated by RP-HPLC on a TSK
gel ODS 120 T column (5 mm, 4.6 250 mm) using a gradient
of acetonitrile in 0.1% TFA. The amino acid sequences of
intact subunits and peptides were determined by a gas-phase
protein sequencer (PPSQ-10; Shimadzu, Japan)17. Sequence
similarities between ASTI and other trypsin inhibitors were
performed using BLAST tools available on the NCBI website
(http://blast.ncbi.nlm.nih.gov/). Multiple sequence alignment
was obtained using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/
clustalw2/), and the phylogenetic tree was viewed using
TreeView.
Molecular mass measurements of proteolytic products
The molecular masses of proteolytic products resulting from
fragmentation of ASTI were measured by matrix-assisted laser
desorption ionization time of flight (MALDI-TOF) mass spec-
trometry (Voyager–DETM STR, Applied Biosystems Q4)
17.
Trypsin and chymotrypsin inhibition assays
The inhibitory effects of ASTI on bovine trypsin and chymotryp-
sin were analysed using Z-Gly-Pro-Arg-pNA and N-Suc-Ala-Ala-
Pro-Phe-pNA as substrates, respectively. The effect of two
substrate concentrations with bovine trypsin, in the presence
of varying concentrations of ASTI was studied. The assays were
performed according to the method of Smith et al.18 using 50 mM
Tris-HCl, pH 8.2, containing 10 mM CaCl2, and the absorbance
was recorded at 412 nm. The modes of inhibition and the
Table 1. Purification table of ASTI from 5 g starting material.
Step (fraction)
Total
protein
(mg)
Total
activity
(U)*
Specific
activity
(U/mg)
Purification
(fold)
Yield
(%)
Acetone (AS) 90 12.42 0.14 1 100
IEC (ASb) 15.9 4.20 0.26 1.91 33.8
Affinity (ASb2) 2.1 1.22 0.58 4.22 9.8
RP-HPLC (ASb2b) 1 1.00 1.00 7.22 8.0
*Inhibitory activity: one unit was defined as the amount of protein needed
to inhibit one unit of trypsin activity. One unit of trypsin activity was
defined as the enzyme activity that hydrolyses 25 mmol of Z-Gly-Pro-
Arg-pNA/min under specified conditions.
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Figure 2. Reducing SDS-PAGE patterns of ASTI purified by affinity
chromatography and RP-HPLC. Lane 1, MW markers; lane 2, affinity
purified fraction (ASb2) and lane 3, RP-HPLC purified fraction (ASb2b).
50–10 refer to kilo Dalton values of molecular weight markers.
Figure 3. (a) Separation of peptides generated by digestion of ASTI A-
chain with S. aureus V8 protease. Peptides were separated by RP-HPLC
on a TSK gel ODS 120 T column using a gradient of acetonitrile in 0.1%
TFA. Flow rate was 1.0 mL/min. (b) Separation of peptides generated by
digestion of ASTI A-chain with endoproteinase Arg-C. Peptides were
separated by RP-HPLC on a TSK gel ODS 120 T column using a gradient
of acetonitrile in 0.1% TFA. Flow rate was 1.0 mL/min. (c) Separation of
peptides generated by digestion of ASTI A-chain with Achromobacter
protease I. Peptides were separated by RP-HPLC on a TSK gel ODS
120 T column using a gradient of acetonitrile in 0.1% TFA. Flow rate was
1.0 mL/min.
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inhibition constants were calculated using double Dixon and
enzyme-inhibitor molar ratio plots. For both assays, ASTI was
incubated with the active enzyme for 3 min before the substrate
was added.
Results and discussion
Purification of AS inhibitor
The past few decades have seen a growing interest in the
identification, purification and characterization of novel PIs
from various sources, because of their potent activity in
preventing carcinogenesis in a wide range of in vivo and
in vitro systems, and their use in developing pest resistance
in otherwise susceptible plants5,19. ASTI was purified to a
final homogeneous product via a few chromatographic steps.
The acetone fraction of the inhibitor was subjected to IEC
(Figure 1a), affinity chromatography (Figure 1b) and RP-HPLC
(Figure 1c), yielding the active inhibitor, fraction ASb2b
(ASTI). The four-step purification procedure of ASTI is
shown in Table 1. A 7.2-fold purification of the inhibitor was
achieved with a specific activity of 1.0 U/mg protein. From
the purification table, it can be concluded that the inhibitor
constituted 8% of the total trypsin inhibitory activity of the
seeds of AS.
Molecular mass estimation and homogeneity of inhibitor
Electrophoresis was performed under reducing conditions and
ASTI was identified as two molecular weight bands of approxi-
mately 10 and 16 kDa (Figure 2). Under non-reducing conditions,
one band was visible, indicating an intact protein with a molecular
weight of 26 kDa (figure not shown). It can be concluded from
the results that the inhibitor consisted of two subunits, possibly
linked by disulfide bonds. An inhibitor from Acacia confusa20
displayed two subunits under reducing SDS-PAGE conditions
(15 and 6 kDa) and a single band (21 kDa) under non-reducing
conditions. Similar results (i.e. a two subunit inhibitor) have been
published for other Acacia species. Kortt and Jermyn21 purified
an inhibitor from Acacia elata seeds and obtained two subunits,
15 kDa for the A-chain and 5 kDa for the B-chain, with a single
component under non-reducing SDS-PAGE conditions (20 kDa).
Primary structure
The enzymatic digests of CAM-ASTI (A-chain) with S. aureus V8
protease, endoproteinase Arg-C and Acromobacter protease
I were separated by RP-HPLC, yielding E1–E7, R1–R8 and
K1–K7 (Figure 3a–c, respectively). Amino acid sequencing and
MALDI-TOF mass spectrometry of the peptide fragments derived
from the three enzymatic digestions allowed the determination
Figure 4. Amino acid sequence of the A- and B-chain of ASTI, deduced from protease digestions, RP-HPLC and sequence analysis. (E), S. aureus V8
protease digest of A-chain; (K), Achromobacter protease 1 digest of A-chain and (R), endoproteinase Arg-C digest of A-chain.
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of the complete amino acid sequence of ASTI, shown in Figure 4.
The sequences of the A- and B-chain revealed 140 and 40 amino
acids, respectively. There are five positions showing two amino
acid residues, namely positions 52, 62, 67, 70 and 122 (Figure 4).
The two residues at the first four positions are accounted for
via the following sequences: E6: TQNGMPAKIWTPPRIGFLS;
E7: QQNGMPAKIWSPPRIAFLS; R8: IGFLTPAFYLNIEFQPR;
K7: IWSPPRIGFLSPAFYLNIEFQPRDPPSCL; and for position
122: K3: IMPYRDDYK; R2: IKPYR; E5: DRVFGPFKIMPYRD
DYKIVYCE. The presence of more than one residue at certain
positions in the ASTI A-chain, referred to as a multiplicity of
inhibitor molecular forms, may be ascribed to isoforms. Several
studies on Ser PIs have confirmed this finding20. The sequences of
K5 and R5 showed that endoproteinase Arg-C may also cleave
Lys residues. Arg 65 is the amino acid at the P1 position of
the reactive site of ASTI (Arg 65-Ile 66), being a characteristic
of a trypsin inhibitor22. ClustalW was used to obtain a sequence
comparison with other similar inhibitors from plant seeds
(Figure 5). Sequence identity of approximately 70% was
calculated between the A-chains of ASTI and ACTI22.
Comparing the B-chain sequences of ASTI and Leucaena
leucocephala trypsin inhibitor (LLTI), a 76% similarity was
obtained. Taking into consideration the molecular weight of intact
ASTI from SDS-PAGE analysis (26 kDa), the low Cys content
(four Cys residues) and the molecule being a two chain structure,
ASTI can be considered to be a Kunitz-type inhibitor23. It has
similar properties to a complete Kunitz-type trypsin inhibitor
alpha chain, which contains only three Cys residues and thus
also making it a Kunitz-type inhibitor, as well as 140 amino acid
residues of the A-chain of ASTI, a characteristic of Kunitz
inhibitors. ACTI22 displayed a high sequence identity to the
N-terminal sequence of ASTI (84% comparing residues 1–50),
and it is also a Kunitz-type inhibitor. Kortt and Jermyn21 isolated
two trypsin inhibitors from A. elata seeds, being homogeneous
as judged by gel electrophoresis at pH 4.3 and 8.8, and both
inhibitors co-eluted from a Sephadex G-100 column and had
the same molecular weight of 25 kDa. It can thus be concluded
that properties of ASTI are similar to those of inhibitors from
comparable species. The phylogenetic comparison of ASTI with
other trypsin inhibitors (Figure 6) showed similarities to other
closely related inhibitors, such as ACTI and LLTI. These results
were also confirmed when related to the multiple sequence
alignments (Figure 5).
Inhibition of serine proteinases
For ASTI a Ki of 3.45 109 M was obtained with bovine trypsin
(Figure 7). The Ki value obtained for ASTI can be compared with
that of a trypsin inhibitor purified from Entada scandens seeds
(Ki of 4.9 109 M)3, indicating a very strong and potent
inhibitor. The Ki value of SBTI interacting with bovine trypsin
is in the range of 109 M24, similar to a Ki of 3.5 109 M
obtained (result not shown). The results suggest a high affinity of
ASTI, as well as SBTI, for trypsin. The molar ratio of ASTI:
enzyme showed a value of 0.8:1 for near complete inhibition
of trypsin (result not shown). The Ki value reported for ACTI
was 0.294 109 M20. The latter result indicates that ACTI has
a stronger binding affinity than ASTI.
ASTI            -----------------------KELLVDNEGEMLRN-GGSYYILPAFRGKGGGLTLAKT 36(a)
(b)
ACTI            -----------------------KELL-DADGDILRN-GGAYYILPALRGKGGGLTLAKT 35
LLTI            ------------------------QVLVDLDGDPLYN-GMSYYILPVARGKGGGLELART 35
BVTI            ------------------------EIVLDQNGNPVRNSGGRYYIIPAFRGNGGGLTLTRV 36
KTI             MKSTIFFLFLFCAFTTSYLPSAIADFVLDNEGNPLEN-GGTYYILSDITAFGG-IRAAPT 58
: : * :*: : * *  ***:      ** :  :
ASTI            GDESCPLTVVQARSETQNGMPAKIWSPPRIAFLSPAFYLNIEFQPRDPPS-CLEEYS-IL 94
ACTI            GDESCPLTVVQAQSETKRGLPAVIWTPPKIAILTPGFYLNFEFQPRDLPA-CLQKYS-TL 93
LLTI            GSESCPRTVVQTRSETSRGLPARLASPYRILIGS-NIPLTIEFQPQKPYS-CHGHSSRSL 93
BVTI            GSETCPRTVVQASSEHSNGLPVVISALPRSLFISTSWRVTIRFVGAPT---CIPEPSFWH 93
KTI             GNERCPLTVVQSRNELDKGIGTIISSPYRIRFIAEGHPLSLKFDSFAVIMLCVGIPTEWS 118
* * ** ****:  *   *:   : :  :  : :    : : *        *    :
ASTI            QWTVTGESQEVKIAPKG-EDRVFGPFKIKPYRDD----YKIVYCESDQSRE--------- 140
ACTI            PWKVEGESQEVKIAPKEKEQFLVGSFKIKPYRDD----YKLVYCEGN------------- 136
LLTI            QWKVE-KTQMVKIASSDEEQRLFGPFQIQPYRNH----YKLVYCESESR----------- 137
BVTI            IPQDSELEGAVKVGASD--ERFPLEFRIERVSED---AYKLMHCPSIS--DSCRDLGIAI 146
KTI             VVEDLPEGPAVKIGENK--DAMDGWFRLERVSDDEFNNYKLVFCPQQAEDDKCGDIGISI 176
**:      :     *:::   ::    **:: *
ASTI            ----------------------------------------
ACTI            ----------------------------------------
LLTI            ----------------------------------------
BVTI            D-EEGNRRLVVRDENPLLVRFKKANRDSEN---------- 175
KTI             DHDDGTRRLVVSKNKPLVVQFQKLDKESLAKKNHGLSRSE 216
ASTI            SDDDSCKDLGISID-DENNRLLVVKDGDPLVVQFKKAHHDH--- 40
ACTI            -DDESCKDLGISID-DENNRRLVVKDGHPLAVRFEKAHRSG--- 39
LLTI            NHHDDCRDLGISID-DQQNRLLVVKNGDPLVVQFAKANRGGDD- 42
SBTI            AEDDKCGDIGISIDHDDGTRRLVVSKNKPLVVQFQKVDKSESLQ 44
: * *:***** *:  * ***    **:*:* *: :
Figure 5. (a) Alignment between the sequence of the A-chain of ASTI with other comparative plant seed inhibitor sequences obtained from ClustalW
search. Comparative sequences are obtained with Kunitz-type trypsin inhibitor A chain, ACTI-A (A. confusa), gij299509j; Kunitz-type trypsin inhibitor
A-chain, LLTI-A (L. leucocephala), gij18202442j; trypsin inhibitor A-chain BVTI-A (Bauhinia variegata), gij15082208j and KTI A-chain, KTI-A
gij162138868j. (*), Identical sequences; (:), similarities of three or four amino acids. (b) Alignment between the sequence of the B-chain of ASTI with
other comparative plant seed inhibitor sequences obtained from ClustalW search. Comparative sequences are obtained with Kunitz-type trypsin
inhibitor B-chain, ACTI-B (A. confusa), gij299508j; SBTI and Kunitz-type trypsin inhibitor B-chain, LLTI-B (L. leucocephala), gij18202443j. (*),
Identical sequences; (:), similarities of three or four amino acids.
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Chymotrypsin inhibition was determined for ASTI and at an
enzyme: inhibitor molar ratio of 1:1 weak/insignificant inhibition
was observed (result not shown). A similar finding was also
observed with inhibitors purified from seeds from Mimosoideae
families, where inhibitors of trypsin were found to also weakly
inhibit chymotrypsin21Q5 .and with inhibitors purified from A. elata
seeds21, A. confusa seeds20 and E. scandens seeds3. However,
recently Lam and Ng25 purified a 70 kDa chymotrypsin inhibitor
from A. confusa seeds that had no trypsin inhibitory activity and
was highly potent in inhibiting HIV-1 reverse transcriptase.
Conclusion
The results revealed that we purified a new PI from seeds of the
Leguminosae, and in terms of the physicochemical and kinetic
properties, ASTI can be considered a Kunitz-type trypsin
inhibitor. In ongoing experiments the effect of ASTI on the
blood coagulation system is studied.
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Figure 6. A phylogenetic tree analysis of ASTI with other inhibitors.
Protein sequences were obtained from http://blast.ncbi.nlm.nih.gov/ by
a BLAST search of ASTI. Accession numbers for the sequences used are
as follows: trypsin isoinhibitor (Adenanthera pavonina), APTI,
gij225058j; LLTI, gij18202442j; Prosopis juliflora trypsin inhibitor,
PJTI, gij417176j; ACTI, gij299509j; Tamarindus indica trypsin inhibitor,
TITI, gij308756025j; BVTI, gij32363181j; Bauhinia ungulate Factor X
inhibitor, BUXI, gij32363179j; Psophocarpus tetragonolobus trypsin
inhibitor, PTTI, gij86450987, chymotrypsin inhibitor (Erythrina varie-
gate), gij265716j. The scale bar shows a branch length of 0.1 (i.e. a 10%
difference in amino acids).
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Figure 7. Double–Dixon plot to determine the inhibition constant (Ki)
of ASTI interacting with bovine trypsin. Substrate concentrations of 25
and 5 mM were used. Bovine trypsin concentration was 1 nM. 25 mM ( )
(R2¼ 0.913) and 5 mM (R2¼ 0.920) ( ).
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